Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Metronidazole can cause lung disease.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

The patient improved after antiviral treatment for a viral infection.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Some gonadal hormone drugs can block filovirus entry into cells.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Six existing drugs may help block virus entry in COVID-19.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Infectious virus was not found after the third remdesivir dose, suggesting early end of isolation is possible.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.